Amgen, Astellas Bring Tally Of US Charity Co-Pay Kickback Settlements To Eight
Astellas to pay $100m and Amgen to pay $24.75m to resolve allegations they paid Medicare copays for their products through copay assistance foundations.
You may also be interested in...
Co-Pay Charity Settles Charges It Conspired With Teva, Biogen, Novartis On Kickbacks
The Assistance Fund directed donations received from the companies to patients taking their multiple sclerosis drugs, the US Department of Justice announced. Further settlements may be pending.
DOJ Casting Wider Net In Pharma Kickback Probes
Government is pursuing behavior it once would have taken a pass on, former DOJ attorney notes; pharma companies have inked 16 settlements in past year.
Mallinckrodt Settles Portion Of DOJ's Acthar Gel Kickback Claims; Charity Copay Probe Continues
$15.4m fine will resolve claims of "wining and dining" doctors to get them to prescribe Acthar. Mallinckrodt dropped NORD and switched to Chronic Disease Fund to administer its copay assistance program, a move that Mallinckrodt’s COO purportedly described as "mom & pop vs. WalMart."